招商局港口(00144.HK)引入5G等技術推動智慧碼頭建設
招商局港口(00144.HK)董事總經理白景濤指,在2月和3月,因應新冠肺炎疫情發展,物流受阻,令港口出現貨提不出去的情況,但4月情況已經改善,會積極和當地政府協調,包括尋找新的場地、利用港口網絡資源、伙伴調動等協助客戶。
他指,集團會推動智慧化港口建設,包括自動化,引入AI、5G等的新科技提升效率;同時亦積極在資本管理上作改善,透過新的融資方式降低利息成本。
他又指,在疫情下,原有訂單雖有受影響,但預期在疫情後會有新訂單補充,包括傳統、過去訂單恢復和防疫物品貨量提升,不過整體仍有影響,相信不會有斷崖式下降。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.